AI-designed universal coronavirus vaccine passes first human trial
A universal coronavirus vaccine designed entirely by AI has successfully passed its first human clinical trial. The vaccine targets a broad range of Sarbeco coronaviruses, offering potential protection against both current and future pandemic threats.
Why it matters
This marks a historic milestone in medical science, proving that AI-generated antigens can be safe and effective for human use, potentially accelerating future vaccine development.
A new type of universal coronavirus vaccine has passed its first human clinical trial, marking an important step toward broader protection against future virus outbreaks.
The article provides a factual account of a scientific study published in a peer-reviewed journal.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in